A phase 3, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of Selonsertib in subjects with compensated cirrhosis due to Nonalcoholic Steatohepatitis (NASH)
- Hodge, Alex, (Primary Chief Investigator (PCI))
Project: Research